Home › Companies › ANI Pharmaceuticals, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and ANI Pharmaceuticals, Inc.’s Form 8-K, filed 2026-05-21 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore ANI Pharmaceuticals, Inc. in the interactive database Compare manager voting policies
These tallies are ANI Pharmaceuticals, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-21 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Thomas Haughey | 14,732,894 | 159,765 | 3,166 | -- | 2,030,222 | Majority: yes |
| Elect Director: Nikhil Lalwani | 14,873,796 | 15,198 | 6,831 | -- | 2,030,222 | Majority: yes |
| Elect Director: Matthew J. Leonard, R.Ph. | 14,743,471 | 149,095 | 3,259 | -- | 2,030,222 | Majority: yes |
| Elect Director: Antonio R. Pera | 14,542,012 | 350,649 | 3,164 | -- | 2,030,222 | Majority: yes |
| Elect Director: Muthusamy Shanmugam | 14,849,624 | 42,253 | 3,948 | -- | 2,030,222 | Majority: yes |
| Elect Director: Renee P. Tannenbaum, Pharm.D. | 14,063,620 | 829,566 | 2,639 | -- | 2,030,222 | Majority: yes |
| Elect Director: Jeanne A. Thoma | 14,565,758 | 327,393 | 2,674 | -- | 2,030,222 | Majority: yes |
| Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year en | 16,874,103 | 7,333 | 44,611 | -- | -- | Majority: yes |
| Proposal 3: Approval of the Say-on-Pay Proposal The vote with respect to the approval of the compensation of the Company's named executive officers, on an advisory basis, was as follows: | 13,819,988 | 1,058,460 | 17,377 | -- | 2,030,222 | Majority: yes |
| Proposal 5: Approval of the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan was as follows: | 13,806,050 | 1,080,387 | 9,388 | -- | 2,030,222 | Majority: yes |
Source: ANI Pharmaceuticals, Inc., Form 8-K, filed with the SEC on 2026-05-21 — read the filing on EDGAR.
Each item below shows how the 323 asset managers that disclosed a ANI Pharmaceuticals, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ANI Pharmaceuticals, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 9 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Proposal 3: Approval of the Say-on-Pay Proposal The vote with respect to the approval of the compensation of the Company's named executive officers, on an advisory basis, was as follows:”): 13,819,988 for, 1,058,460 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 61% for, 5% against (66% of the company cast a for/against vote).
The 322 asset managers below cast 92% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,987,771 | 0 | 0 | 0 | For |
| Vanguard | 1,399,892 | 3 | 0 | 0 | For |
| State Street | 692,249 | 0 | 0 | 0 | For |
| GOLDENTREE ASSET MANAGEMENT LP | 613,386 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 600,000 | 0 | 0 | 0 | For |
| Nuveen | 542,176 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 482,207 | 0 | 0 | 0 | For |
| Fidelity | 472,270 | 0 | 0 | 0 | For |
| Charles Schwab | 441,792 | 0 | 0 | 0 | For |
| Ranger Investment Management, L.P. | 311,918 | 0 | 0 | 0 | For |
| Soleus Capital Management, L.P. | 311,676 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 287,264 | 0 | 0 | 0 | For |
| American Century | 0 | 285,672 | 0 | 0 | Against |
| Aberdeen | 0 | 271,552 | 0 | 0 | Against |
| Global Alpha Capital Management Ltd. | 0 | 265,797 | 0 | 0 | Against |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 257,987 | 0 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 227,764 | 0 | 0 | 0 | For |
| OBERWEIS ASSET MANAGEMENT INC/ | 220,340 | 0 | 0 | 0 | For |
| Freestone Grove Partners LP | 214,545 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Dimensional | 209,276 | 0 | 0 | 0 | For |
| Janus Henderson | 203,914 | 0 | 0 | 0 | For |
| Waddell & Reed | 196,758 | 0 | 0 | 0 | For |
Showing the 25 largest of 322 asset managers. See all 322 in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% fund support · no official result
The 220 asset managers below cast 100% of the shares they voted on this item FOR (70,711 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | One Year |
| State Street | 0 | 0 | 0 | 0 | One Year |
| Nuveen | 0 | 0 | 0 | 0 | One Year |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| Fidelity | 0 | 0 | 0 | 0 | One Year |
| Charles Schwab | 0 | 0 | 0 | 0 | 1 Year |
| Ranger Investment Management, L.P. | 0 | 0 | 0 | 0 | One Year |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 0 | 0 | 0 | One Year |
| American Century | 0 | 0 | 0 | 0 | One Year |
| Aberdeen | 0 | 0 | 0 | 0 | One Year |
| Global Alpha Capital Management Ltd. | 0 | 0 | 0 | 0 | One Year |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| TIAA | 0 | 0 | 0 | 0 | One Year |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | One Year |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0 | 0 | 0 | 0 | One Year |
| OBERWEIS ASSET MANAGEMENT INC/ | 0 | 0 | 0 | 0 | One Year |
| Freestone Grove Partners LP | 0 | 0 | 0 | 0 | One Year |
| OBERWEIS FUNDS | 0 | 0 | 0 | 0 | One Year |
| Dimensional | 0 | 0 | 0 | 0 | Three Years |
| Janus Henderson | 0 | 0 | 0 | 0 | One Year |
| Waddell & Reed | 0 | 0 | 0 | 0 | One Year |
| SEI | 0 | 0 | 0 | 0 | 1 Year |
| KENNEDY CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | One Year |
| Victory Capital | 0 | 0 | 0 | 0 | One Year |
| Russell Investments | 0 | 0 | 0 | 0 | 1 Year |
Showing the 25 largest of 220 asset managers. See all 220 in the interactive database.
Combines 2 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Proposal 5: Approval of the Amended 2022 Stock Plan The vote with respect to the approval of the Amended 2022 Stock Plan was as follows:”): 13,806,050 for, 1,080,387 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 61% for, 5% against (66% of the company cast a for/against vote).
The 96 asset managers below cast 95% of the shares they voted on this item FOR (6,560,854 for, 376,450 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,284,439 | 0 | 0 | 0 | For |
| Vanguard | 1,244,466 | 4,685 | 0 | 0 | For |
| Fidelity | 453,967 | 0 | 0 | 0 | For |
| State Street | 359,105 | 464 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Charles Schwab | 210,097 | 0 | 0 | 0 | For |
| Waddell & Reed | 196,758 | 0 | 0 | 0 | For |
| Invesco | 149,481 | 0 | 0 | 0 | For |
| Nuveen | 144,231 | 0 | 0 | 0 | For |
| American Century | 0 | 141,262 | 0 | 0 | Against |
| Dimensional | 134,821 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 122,741 | 0 | 0 | 0 | For |
| DWS | 102,655 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 99,697 | 0 | 0 | 0 | For |
| First Trust | 98,300 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 0 | 85,830 | 0 | 0 | Against |
| World Funds Trust | 5,750 | 77,956 | 0 | 0 | Against |
| Aberdeen | 81,505 | 0 | 0 | 0 | For |
| SEI | 76,357 | 1,928 | 0 | 0 | For |
| Empower | 73,636 | 0 | 0 | 0 | For |
| Victory Capital | 66,600 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 60,000 | 0 | 0 | Against |
| OLD WESTBURY FUNDS INC | 57,722 | 0 | 0 | 0 | For |
Showing the 25 largest of 96 asset managers. See all 96 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Thomas Haughey”): 14,732,894 for, 159,765 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 66% for, 0.8% against (66% of the company cast a for/against vote).
The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (7,073,263 for, 3,971 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,284,439 | 0 | 0 | 0 | For |
| Vanguard | 1,246,699 | 2,452 | 0 | 0 | For |
| Fidelity | 453,967 | 0 | 0 | 0 | For |
| State Street | 359,569 | 0 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Charles Schwab | 210,097 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 200,000 | 0 | 0 | 0 | For |
| Waddell & Reed | 196,758 | 0 | 0 | 0 | For |
| Invesco | 149,481 | 0 | 0 | 0 | For |
| Nuveen | 144,231 | 0 | 0 | 0 | For |
| American Century | 141,262 | 0 | 0 | 0 | For |
| Dimensional | 134,821 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 122,741 | 0 | 0 | 0 | For |
| DWS | 102,655 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 99,697 | 0 | 0 | 0 | For |
| First Trust | 98,300 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 85,830 | 0 | 0 | 0 | For |
| World Funds Trust | 83,706 | 0 | 0 | 0 | For |
| Aberdeen | 81,505 | 0 | 0 | 0 | For |
| SEI | 78,285 | 0 | 0 | 0 | For |
| Empower | 73,636 | 0 | 0 | 0 | For |
| Victory Capital | 66,600 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 57,722 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Antonio R. Pera”): 14,542,012 for, 350,649 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 65% for, 2% against (66% of the company cast a for/against vote).
The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (7,077,232 for, 2 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,284,439 | 0 | 0 | 0 | For |
| Vanguard | 1,249,149 | 2 | 0 | 0 | For |
| Fidelity | 453,967 | 0 | 0 | 0 | For |
| State Street | 359,569 | 0 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Charles Schwab | 210,097 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 200,000 | 0 | 0 | 0 | For |
| Waddell & Reed | 196,758 | 0 | 0 | 0 | For |
| Invesco | 149,481 | 0 | 0 | 0 | For |
| Nuveen | 144,231 | 0 | 0 | 0 | For |
| American Century | 141,262 | 0 | 0 | 0 | For |
| Dimensional | 134,821 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 122,741 | 0 | 0 | 0 | For |
| DWS | 102,655 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 99,697 | 0 | 0 | 0 | For |
| First Trust | 98,300 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 85,830 | 0 | 0 | 0 | For |
| World Funds Trust | 83,706 | 0 | 0 | 0 | For |
| Aberdeen | 81,505 | 0 | 0 | 0 | For |
| SEI | 78,285 | 0 | 0 | 0 | For |
| Empower | 73,636 | 0 | 0 | 0 | For |
| Victory Capital | 66,600 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 57,722 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Jeanne A. Thoma”): 14,565,758 for, 327,393 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 65% for, 1% against (66% of the company cast a for/against vote).
The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (6,937,232 for, 2 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,284,439 | 0 | 0 | 0 | For |
| Vanguard | 1,249,149 | 2 | 0 | 0 | For |
| Fidelity | 453,967 | 0 | 0 | 0 | For |
| State Street | 359,569 | 0 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Charles Schwab | 210,097 | 0 | 0 | 0 | For |
| Waddell & Reed | 196,758 | 0 | 0 | 0 | For |
| Invesco | 149,481 | 0 | 0 | 0 | For |
| Nuveen | 144,231 | 0 | 0 | 0 | For |
| American Century | 141,262 | 0 | 0 | 0 | For |
| Dimensional | 134,821 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 122,741 | 0 | 0 | 0 | For |
| DWS | 102,655 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 99,697 | 0 | 0 | 0 | For |
| First Trust | 98,300 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 85,830 | 0 | 0 | 0 | For |
| World Funds Trust | 83,706 | 0 | 0 | 0 | For |
| Aberdeen | 81,505 | 0 | 0 | 0 | For |
| SEI | 78,285 | 0 | 0 | 0 | For |
| Empower | 73,636 | 0 | 0 | 0 | For |
| Victory Capital | 66,600 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 60,000 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 57,722 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Matthew J. Leonard, R.Ph.”): 14,743,471 for, 149,095 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 66% for, 0.7% against (66% of the company cast a for/against vote).
The 95 asset managers below cast 99.9% of the shares they voted on this item FOR (7,075,715 for, 1,519 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,284,439 | 0 | 0 | 0 | For |
| Vanguard | 1,249,151 | 0 | 0 | 0 | For |
| Fidelity | 453,967 | 0 | 0 | 0 | For |
| State Street | 359,569 | 0 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Charles Schwab | 210,097 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 200,000 | 0 | 0 | 0 | For |
| Waddell & Reed | 196,758 | 0 | 0 | 0 | For |
| Invesco | 149,481 | 0 | 0 | 0 | For |
| Nuveen | 144,231 | 0 | 0 | 0 | For |
| American Century | 141,262 | 0 | 0 | 0 | For |
| Dimensional | 134,821 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 122,741 | 0 | 0 | 0 | For |
| DWS | 102,655 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 99,697 | 0 | 0 | 0 | For |
| First Trust | 98,300 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 85,830 | 0 | 0 | 0 | For |
| World Funds Trust | 83,706 | 0 | 0 | 0 | For |
| Aberdeen | 81,505 | 0 | 0 | 0 | For |
| SEI | 78,285 | 0 | 0 | 0 | For |
| Empower | 73,636 | 0 | 0 | 0 | For |
| Victory Capital | 66,600 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 57,722 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Muthusamy Shanmugam”): 14,849,624 for, 42,253 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 66% for, 0.2% against (66% of the company cast a for/against vote).
The 95 asset managers below cast 100% of the shares they voted on this item FOR (7,077,234 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,284,439 | 0 | 0 | 0 | For |
| Vanguard | 1,249,151 | 0 | 0 | 0 | For |
| Fidelity | 453,967 | 0 | 0 | 0 | For |
| State Street | 359,569 | 0 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Charles Schwab | 210,097 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 200,000 | 0 | 0 | 0 | For |
| Waddell & Reed | 196,758 | 0 | 0 | 0 | For |
| Invesco | 149,481 | 0 | 0 | 0 | For |
| Nuveen | 144,231 | 0 | 0 | 0 | For |
| American Century | 141,262 | 0 | 0 | 0 | For |
| Dimensional | 134,821 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 122,741 | 0 | 0 | 0 | For |
| DWS | 102,655 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 99,697 | 0 | 0 | 0 | For |
| First Trust | 98,300 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 85,830 | 0 | 0 | 0 | For |
| World Funds Trust | 83,706 | 0 | 0 | 0 | For |
| Aberdeen | 81,505 | 0 | 0 | 0 | For |
| SEI | 78,285 | 0 | 0 | 0 | For |
| Empower | 73,636 | 0 | 0 | 0 | For |
| Victory Capital | 66,600 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 57,722 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Nikhil Lalwani”): 14,873,796 for, 15,198 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 66% for, 0.1% against (66% of the company cast a for/against vote).
The 95 asset managers below cast 100% of the shares they voted on this item FOR (7,077,234 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,284,439 | 0 | 0 | 0 | For |
| Vanguard | 1,249,151 | 0 | 0 | 0 | For |
| Fidelity | 453,967 | 0 | 0 | 0 | For |
| State Street | 359,569 | 0 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Charles Schwab | 210,097 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 200,000 | 0 | 0 | 0 | For |
| Waddell & Reed | 196,758 | 0 | 0 | 0 | For |
| Invesco | 149,481 | 0 | 0 | 0 | For |
| Nuveen | 144,231 | 0 | 0 | 0 | For |
| American Century | 141,262 | 0 | 0 | 0 | For |
| Dimensional | 134,821 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 122,741 | 0 | 0 | 0 | For |
| DWS | 102,655 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 99,697 | 0 | 0 | 0 | For |
| First Trust | 98,300 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 85,830 | 0 | 0 | 0 | For |
| World Funds Trust | 83,706 | 0 | 0 | 0 | For |
| Aberdeen | 81,505 | 0 | 0 | 0 | For |
| SEI | 78,285 | 0 | 0 | 0 | For |
| Empower | 73,636 | 0 | 0 | 0 | For |
| Victory Capital | 66,600 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 57,722 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Elect Director: Renee P. Tannenbaum, Pharm.D.”): 14,063,620 for, 829,566 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 63% for, 4% against (66% of the company cast a for/against vote).
The 95 asset managers below cast 96% of the shares they voted on this item FOR (6,858,773 for, 268,461 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,284,439 | 0 | 0 | 0 | For |
| Vanguard | 1,246,696 | 2,455 | 0 | 0 | For |
| Fidelity | 453,967 | 0 | 0 | 0 | For |
| State Street | 359,569 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 250,000 | 0 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Charles Schwab | 210,097 | 0 | 0 | 0 | For |
| Waddell & Reed | 0 | 196,758 | 0 | 0 | Against |
| Invesco | 149,481 | 0 | 0 | 0 | For |
| Nuveen | 144,231 | 0 | 0 | 0 | For |
| American Century | 141,262 | 0 | 0 | 0 | For |
| Dimensional | 134,821 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 122,741 | 0 | 0 | 0 | For |
| DWS | 102,655 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 99,697 | 0 | 0 | 0 | For |
| First Trust | 98,300 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 85,830 | 0 | 0 | 0 | For |
| World Funds Trust | 83,706 | 0 | 0 | 0 | For |
| Aberdeen | 81,505 | 0 | 0 | 0 | For |
| SEI | 78,285 | 0 | 0 | 0 | For |
| Empower | 73,636 | 0 | 0 | 0 | For |
| Victory Capital | 66,600 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 57,722 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
Combines 2 wordings of this item as funds reported it.
— fund support · no official result
No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | 1 Year |
| GOLDENTREE ASSET MANAGEMENT LP | 0 | 0 | 0 | 0 | 1 Year |
| Deep Track Capital, LP | 0 | 0 | 0 | 0 | 1 Year |
| Soleus Capital Management, L.P. | 0 | 0 | 0 | 0 | 1 Year |
| RBB FUND, INC. | 0 | 0 | 0 | 0 | 1 Year |
| F/m Investments LLC | 0 | 0 | 0 | 0 | 1 Year |
| Northern Trust | 0 | 0 | 0 | 0 | 1 Year |
| Pacer Funds Trust | 0 | 0 | 0 | 0 | 1 Year |
| World Funds Trust | 0 | 0 | 0 | 0 | 1 Year |
| CARILLON SERIES TRUST | 0 | 0 | 0 | 0 | 1 Year |
| Loomis Sayles | 0 | 0 | 0 | 0 | 1 Year |
| Jackson National | 0 | 0 | 0 | 0 | 1 Year |
| Securian Funds Trust | 0 | 0 | 0 | 0 | 1 Year |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | 1 Year |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | 1 Year |
| Natixis | 0 | 0 | 0 | 0 | 1 Year |
| Pear Tree Funds | 0 | 0 | 0 | 0 | 1 Year |
| RBB Fund Trust | 0 | 0 | 0 | 0 | 1 Year |
| Ellsworth Advisors, LLC | 0 | 0 | 0 | 0 | 3 Years |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 0 | 0 | 0 | 0 | 1 Year |
| Wakefield Asset Management LLLP | 0 | 0 | 0 | 0 | 1 Year |
| Sanctuary Advisors, LLC | 0 | 0 | 0 | 0 | 1 Year |
| Allianz | 0 | 0 | 0 | 0 | 1 Year |
| Lighthouse Investment Partners, LLC | 0 | 0 | 0 | 0 | 1 Year |
| John Hancock | 0 | 0 | 0 | 0 | 1 Year |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
ANI Pharmaceuticals, Inc.’s own tally for this item (“Proposal 2: Ratification of the Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of the appointment of Ernst & Young LLP as the Company's independent registered publi”): 16,874,103 for, 7,333 against, per its Form 8-K filed 2026-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 22,491,281 outstanding shares: 75% for, 0.1% against (75% of the company cast a for/against vote).
The 95 asset managers below cast 100% of the shares they voted on this item FOR (6,937,234 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,284,439 | 0 | 0 | 0 | For |
| Vanguard | 1,249,151 | 0 | 0 | 0 | For |
| Fidelity | 453,967 | 0 | 0 | 0 | For |
| State Street | 359,569 | 0 | 0 | 0 | For |
| TIAA | 244,260 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 231,181 | 0 | 0 | 0 | For |
| OBERWEIS FUNDS | 212,500 | 0 | 0 | 0 | For |
| Charles Schwab | 210,097 | 0 | 0 | 0 | For |
| Waddell & Reed | 196,758 | 0 | 0 | 0 | For |
| Invesco | 149,481 | 0 | 0 | 0 | For |
| Nuveen | 144,231 | 0 | 0 | 0 | For |
| American Century | 141,262 | 0 | 0 | 0 | For |
| Dimensional | 134,821 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 122,741 | 0 | 0 | 0 | For |
| DWS | 102,655 | 0 | 0 | 0 | For |
| Janus Detroit Street Trust | 99,697 | 0 | 0 | 0 | For |
| First Trust | 98,300 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 85,830 | 0 | 0 | 0 | For |
| World Funds Trust | 83,706 | 0 | 0 | 0 | For |
| Aberdeen | 81,505 | 0 | 0 | 0 | For |
| SEI | 78,285 | 0 | 0 | 0 | For |
| Empower | 73,636 | 0 | 0 | 0 | For |
| Victory Capital | 66,600 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 60,000 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 57,722 | 0 | 0 | 0 | For |
Showing the 25 largest of 95 asset managers. See all 95 in the interactive database.
100% fund support · no official result
The 7 asset managers below cast 100% of the shares they voted on this item FOR (41,834 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| GLOBEFLEX CAPITAL L P | 41,834 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 0 | 0 | 0 | Not Voted |
| Empower | 0 | 0 | 0 | 0 | One Year |
| Vinva Investment Management Ltd | 0 | 0 | 0 | 0 | 1 Year |
| Integrated Quantitative Investments LLC | 0 | 0 | 0 | 0 | 1 Year |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 0 | One Year |
| Convergence Investment Partners, LLC | 0 | 0 | 0 | 0 | 1 |
Ranked by the number of ANI Pharmaceuticals, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 22,491,281 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 8.84% |
| 2 | Vanguard | 6.22% |
| 3 | State Street | 3.08% |
| 4 | GOLDENTREE ASSET MANAGEMENT LP | 2.73% |
| 5 | Deep Track Capital, LP | 2.67% |
| 6 | Nuveen | 2.41% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.14% |
| 8 | Fidelity | 2.10% |
| 9 | Charles Schwab | 1.96% |
| 10 | Ranger Investment Management, L.P. | 1.39% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 12.22% | 13F |
| Vanguard Group | 5.80% | 13F |
| State Street | 3.43% | 13F |
| Millennium Management | 2.63% | 13F |
| Dimensional Fund Advisors | 2.36% | 13F |
| Muthusamy Shanmugam | 2.31% | DEF14A |
| Geode Capital | 2.18% | 13F |
| Nikhil Lalwani | 1.90% | DEF14A |
| Invesco | 1.44% | 13F |
| Morgan Stanley | 1.25% | 13F |
Percentages above are of 22,491,281 shares outstanding, as reported by ANI Pharmaceuticals, Inc. on its Form 10-K dated 2025-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ANI Pharmaceuticals, Inc.’s 10-K dated 2025-12-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At ANI Pharmaceuticals, Inc.'s shareholder meeting held 2026-05-21, in the 2025-2026 proxy season, 323 asset managers reported how they voted in their SEC Form N-PX filings, covering 4,059 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve the compensation of the Company's named executive officers, on a non-binding… — FOR was 93% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ANI Pharmaceuticals, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-21.
ANI Pharmaceuticals, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).